Fondazione Michelangelo Breast Cancer Group (FM-B)

[摘要] This section provides current contact details and a summary of recent or ongoing clinical trials being coordinated by Fondazione Michelangelo Breast Cancer Group (FM-B). Clinical trials include:European cooperative study of chemotherapy and surgery comparing adjuvant doxorubicin followed by CMF versus adjuvant doxorubicin/paclitaxel followed by CMF versus primary doxorubicin/paclitaxel followed by CMF in women with operable breast cancer and T > 2cm.European Cooperative Study of Primary Systemic Therapy in Women with Operable Breast Cancer and T > 2cm.

[学科分类] 肿瘤学